(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Get away from the Tedious Drudgery: Go into Business Today! - 2NASA just launched Artemis 2. What happens today could make or break the moon mission
- 3The most effective method to Arrange a Higher Medical caretaker Pay During Your Next New employee screening
- 4Whale stranded off Germany for days is stuck again
- 5What's going around right now? COVID, flu, stomach bug on the rise
- Meet ‘NASA Mike,’ who’s done 105,000 handstands around the world
- The Force of Mentorship: Self-improvement through Direction
- 5 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action
- Apollo vs. Artemis: What to know about NASA's return to the moon
- Hundreds show fascist salute at rally in Rome in annual ritual
- I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- Party Urban areas of the World
- The Century Coupe Could Be Toyota’s Most Ambitious Car Since the LFA
- Hezbollah uses ambulances, paramedic uniforms, as disguise for terrorist activity, IDF says
